Carcinoma, Adenosquamous: A mixed adenocarcinoma and squamous cell or epidermoid carcinoma.Carcinoma: A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm but is often wrongly used as a synonym for "cancer." (From Dorland, 27th ed)Carcinoma, Squamous Cell: A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)Adenocarcinoma: A malignant epithelial tumor with a glandular organization.Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.Uterine Cervical Neoplasms: Tumors or cancer of the UTERINE CERVIX.Lung Neoplasms: Tumors or cancer of the LUNG.Plutonium: Plutonium. A naturally radioactive element of the actinide metals series. It has the atomic symbol Pu, atomic number 94, and atomic weight 242. Plutonium is used as a nuclear fuel, to produce radioisotopes for research, in radionuclide batteries for pacemakers, and as the agent of fission in nuclear weapons.Lacrimal Apparatus Diseases: Diseases of the lacrimal apparatus.Gallbladder Neoplasms: Tumors or cancer of the gallbladder.Immunohistochemistry: Histochemical localization of immunoreactive substances using labeled antibodies as reagents.Duodenogastric Reflux: Retrograde flow of duodenal contents (BILE ACIDS; PANCREATIC JUICE) into the STOMACH.Carcinoma in Situ: A lesion with cytological characteristics associated with invasive carcinoma but the tumor cells are confined to the epithelium of origin, without invasion of the basement membrane.Pancreatic Neoplasms: Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).Pancreatectomy: Surgical removal of the pancreas. (Dorland, 28th ed)Fatal Outcome: Death resulting from the presence of a disease in an individual, as shown by a single case report or a limited number of patients. This should be differentiated from DEATH, the physiological cessation of life and from MORTALITY, an epidemiological or statistical concept.Prognosis: A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations.Neoplasm Staging: Methods which attempt to express in replicable terms the extent of the neoplasm in the patient.Tumor Markers, Biological: Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or body fluids. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including hormones, antigens, amino and nucleic acids, enzymes, polyamines, and specific cell membrane proteins and lipids.Carcinoma, Papillary: A malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells. (Stedman, 25th ed)Papillomaviridae: A family of small, non-enveloped DNA viruses infecting birds and most mammals, especially humans. They are grouped into multiple genera, but the viruses are highly host-species specific and tissue-restricted. They are commonly divided into hundreds of papillomavirus "types", each with specific gene function and gene control regions, despite sequence homology. Human papillomaviruses are found in the genera ALPHAPAPILLOMAVIRUS; BETAPAPILLOMAVIRUS; GAMMAPAPILLOMAVIRUS; and MUPAPILLOMAVIRUS.Survival Rate: The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods.Liver Neoplasms: Tumors or cancer of the LIVER.Microdissection: The performance of dissections with the aid of a microscope.Carcinoma, Ductal, Breast: An invasive (infiltrating) CARCINOMA of the mammary ductal system (MAMMARY GLANDS) in the human BREAST.Keratins: A class of fibrous proteins or scleroproteins that represents the principal constituent of EPIDERMIS; HAIR; NAILS; horny tissues, and the organic matrix of tooth ENAMEL. Two major conformational groups have been characterized, alpha-keratin, whose peptide backbone forms a coiled-coil alpha helical structure consisting of TYPE I KERATIN and a TYPE II KERATIN, and beta-keratin, whose backbone forms a zigzag or pleated sheet structure. alpha-Keratins have been classified into at least 20 subtypes. In addition multiple isoforms of subtypes have been found which may be due to GENE DUPLICATION.Carcinoma, Basal Cell: A malignant skin neoplasm that seldom metastasizes but has potentialities for local invasion and destruction. Clinically it is divided into types: nodular, cicatricial, morphaic, and erythematoid (pagetoid). They develop on hair-bearing skin, most commonly on sun-exposed areas. Approximately 85% are found on the head and neck area and the remaining 15% on the trunk and limbs. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1471)Carcinoma, Non-Small-Cell Lung: A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy.Lymphatic Metastasis: Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system.Retrospective Studies: Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.Papillomavirus Infections: Neoplasms of the skin and mucous membranes caused by papillomaviruses. They are usually benign but some have a high risk for malignant progression.Pancreaticoduodenectomy: The excision of the head of the pancreas and the encircling loop of the duodenum to which it is connected.Receptor, Epidermal Growth Factor: A cell surface receptor involved in regulation of cell growth and differentiation. It is specific for EPIDERMAL GROWTH FACTOR and EGF-related peptides including TRANSFORMING GROWTH FACTOR ALPHA; AMPHIREGULIN; and HEPARIN-BINDING EGF-LIKE GROWTH FACTOR. The binding of ligand to the receptor causes activation of its intrinsic tyrosine kinase activity and rapid internalization of the receptor-ligand complex into the cell.Mutation: Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.Carcinoma, Transitional Cell: A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS.Morbidity: The proportion of patients with a particular disease during a given year per given unit of population.DNA Mutational Analysis: Biochemical identification of mutational changes in a nucleotide sequence.

Human papillomavirus DNA in adenosquamous carcinoma of the lung. (1/236)

AIM: To investigate the presence of human papillomavirus (HPV) DNA in adenosquamous carcinoma of the lung--which is relatively common in Okinawa but not in mainland Japan--and examine its histological features. METHODS: Of 207 cases where primary lung cancers were surgically removed between January 1995 and June 1997 in Okinawa, 23 were adenosquamous carcinoma. HPV was detected by non-isotopic in situ hybridisation (NISH) and polymerase chain reaction (PCR) amplification with primers specific for E6 and E7 regions of the HPV genome. PCR products were analysed by Southern blotting. Immunohistochemical determination of high molecular weight cytokeratin (HMC) and involucrin was also carried out. RESULTS: 18 cases were positive for HPV DNA by PCR and NISH. HPV types 6, 11, 16, and 18 were found. Seven cases were dual positive for different types of HPV. Using NISH, HPV was also found in the squamous cell components and in neighbouring enlarged adenocarcinoma cells. The HMC and involucrin were demonstrated immunohistochemically in the same areas. CONCLUSIONS: HPV DNA was found in a high proportion (78.3%) of adenosquamous carcinomas in Okinawa, a region where HPV has previously been shown to be prevalent in squamous cell carcinoma of the lung. The adenocarcinoma cells adjacent to the squamous cell carcinoma component were enlarged and positive for HPV, HMC, and involucrin. This is thought to indicate the transition from adenocarcinoma to squamous cell carcinoma.  (+info)

Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. (2/236)

PURPOSE: In 1986, a protocol comparing primary radiation therapy (RT) plus hydroxyurea (HU) to irradiation plus fluorouracil (5-FU) and cisplatin (CF) was activated by the Gynecologic Oncology Group (GOG) for the treatment of patients with locally advanced cervical carcinoma. The goals were to determine the superior chemoradiation regimen and to quantitate the relative toxicities. METHODS: All patients had biopsy-proven invasive squamous cell carcinoma, adenocarcinoma, or adenosquamous carcinoma of the uterine cervix. Patients underwent standard clinical staging studies and their tumors were found to be International Federation of Gynaecology and Obstetrics stages IIB, III, or IVA. Negative cytologic washings and para-aortic lymph nodes were required for entry. Patients were randomized to receive either standard whole pelvic RT with concurrent 5-FU infusion and bolus CF or the same RT plus oral HU. RESULTS: Of 388 randomized patients, 368 were eligible; 177 were randomized to CF and 191 to HU. Adverse effects were predominantly hematologic or gastrointestinal in both regimens. Severe or life-threatening leukopenia was more common in the HU group (24%) than in the CF group (4%). The difference in progression-free survival (PFS) was statistically significant in favor of the CF group (P = .033). The sites of progression in the two treatment groups were not substantially different. Survival was significantly better for the patients randomized to CF (P = .018). CONCLUSION: This study demonstrates that for patients with locally advanced carcinoma of the cervix, the combination of 5-FU and CF with RT offers patients better PFS and overall survival than HU, and with manageable toxicity.  (+info)

Haematogenous cytokeratin 20 mRNA as a predictive marker for recurrence in oral cancer patients. (3/236)

We examined the expression of cytokeratin 20 (CK20) mRNA in the peripheral blood of oral squamous cell carcinoma (SCC) patients by reverse transcriptase polymerase chain reaction (RT-PCR). Eleven out of 12 oral SCC patients showed positive RT-PCR results. However, there is no clear relationship between the haematogenous CK20 mRNA and the metastasis. After initial treatment, all of the tumour-free survivors tested showed negative RT-PCR results. CK20 mRNA in peripheral blood can be used as a marker for tumour recurrence but not not for metastasis in oral SCC patients.  (+info)

A population-based survey of the management of women with cancer of the cervix. (4/236)

The aim of this study was to investigate the influence of diagnostic throughput on survival outcome for women with cancer of the cervix. We conducted a case note review of 359 women in Lancashire and Greater Manchester diagnosed with cancer of the cervix during 1990, identified from records held by the North Western Regional Cancer Registry. Univariate and multivariate survival analyses were undertaken to investigate the influence on survival of woman, disease and treatment related factors. Following adjustment for woman- and disease-related factors there was no evidence of a statistically significant association between diagnostic throughput and survival. The findings of this study do not support the need for any change in the referral patterns to gynaecologists of women with symptoms suggestive of cancer of the cervix.  (+info)

Overexpression of cyclooxygenase-2 in carcinoma of the pancreas. (5/236)

The level of cyclooxygenase (COX)-2 has been investigated recently in various human carcinomas. In the present study, we examined the distribution and extent of COX-2 protein in human pancreatic tumors using immunohistochemistry. A strong expression of COX-2 protein was present in 23 of 52 (44%) pancreatic carcinomas, a moderate expression was present in 24 of 52 (46%) pancreatic carcinomas, and a weak expression was present in 5 of 52 (10%) pancreatic carcinomas. In contrast, benign tumors showed weak expression or no expression of COX-2, and only islet cells displayed COX-2 expression in normal pancreatic tissues. Overexpression of COX-2 in carcinoma tissues was also confirmed by Western blot analysis. Furthermore, consistent with the results at protein levels, reverse transcription-PCR analyses indicated that COX-2 mRNA was overexpressed in 7 of 13 (54%) carcinomas, but in none of 3 benign tumors. Our findings suggest that COX-2 inhibitors might be potentially effective against pancreatic carcinomas and that COX-2 may be involved in certain biological processes in pancreatic islets.  (+info)

Adenosquamous carcinoma of the prostate. (6/236)

An unusual adenosquamous carcinoma originating in the prostate of a 73-year-old man is described. The histological finding showed a well differentiated squamous cell carcinoma admixed in an adenocarcinomatous area. A transitional area of 2 carcinomatous elements was also noted. Seven months prior to the development of this lesion, a diagnosis of adenocarcinoma had been established by transurethral resection of the prostate and the patient had been treated with bilateral orchiectomy. This is the first case of adenosquamous carcinoma of the prostate reported in Korea. The pathogenesis and previous reports of this lesion will be discussed.  (+info)

Carbonic anhydrase IX antigen differentiates between preneoplastic malignant lesions in non-small cell lung carcinoma. (7/236)

The MaTu interval (MN)/carbonic anhydrase (CA) IX tumour-associated antigen is a protein that is normally expressed in the gut and belongs to the carbonic anhydrase enzyme family (CA IX). It has been detected in tumour cell lines and in some solid tumours including cervical, oesophageal and clear cell renal carcinoma. This study determined MN/CA IX expression in 65 primary non-small cell lung cancer resected with curative intent and in 38 bronchial preneoplastic lesions, carcinoma in situ or microinvasive carcinoma as well as in normal bronchial tissue. The presence of MN/CA IX was detected using immunohistochemistry and Western blot analysis, whenever frozen material was available. Immunostaining was positive in 52/65 (80%) of the tumour samples. The staining was more often focal than diffuse. The percentage of stained cells in positive tumours was highly variable, ranging 1-85%. The pattern of immunostaining was predominantly cytoplasmic with a membranous reinforcement (87%). The intensity was mainly strong (69%). The presence of the protein in the tumour was confirmed by Western blot analysis in the eight samples tested. All the morphologically normal epithelia, except in close vicinity of tumours in some cases, as well as the preneoplastic bronchial lesions (basal cell hyperplasia, metaplasia and dysplasia) were immunonegative for MN/CA IX expression. In contrast, carcinoma in situ and microinvasive epithelioma showed the presence of MN-immunopositive tumoural cells in 5/7 and 4/5 of the samples, respectively. These data suggest that MN/CA IX is a useful marker for the differentiation between preneoplastic lesions and bronchial non-small cell lung cancer in the lung.  (+info)

Inhibitory effects of combined administration of antibiotics and anti-inflammatory drugs on lung tumor development initiated by N-nitrosobis(2-hydroxypropyl)amine in rats. (8/236)

The effects of antibiotics and anti-inflammatory drugs on the promotion stage of lung carcinogenesis initiated with N-nitrosobis(2-hydroxypropyl)amine (BHP) in rats were investigated in two experiments with a similar protocol. In experiment 1, rats received tap water containing 2000 p.p.m. BHP for 12 weeks followed by basal diet or basal diet containing 0.02% erythromycin (EM), 0. 04% ampicillin (ABPC), 1.5% sho-saiko-to, 0.02% EM plus 1.5% sho-saiko-to or 0.04% ABPC plus 1.5% sho-saiko-to for 8 weeks after BHP administration. The development of adenocarcinomas (AC), squamous cell carcinomas (SqC) and adenosquamous carcinomas (ASqC) was completely inhibited in rats given ABPC plus sho-saiko-to and the numbers of lung lesions including alveolar hyperplasias, adenomas and carcinomas were decreased in rats given EM plus sho-saiko-to or ABPC plus sho-saiko-to. Neutrophil and macrophage infiltration into alveolar spaces of the lung were also markedly suppressed. In experiment 2, rats received BHP in the same manner as in experiment 1 and basal diet or basal diet containing 0.04% ABPC, 0.006% piroxicam, 0.04% ABPC plus 0.006% piroxicam and 0.04% ABPC plus 0.75% ougon for 8 weeks. The incidence and number of carcinomas, including ACs, SqCs and ASqCs were decreased in rats given ABPC plus piroxicam or ABPC plus ougon. Bacteria, mainly Escherichia coli, were detected in broncho-alveolar lavage of rats receiving BHP. The results suggest that chronic inflammation might be involved in the progression of lung carcinogenesis by BHP in rats and its suppression may therefore be useful as a chemopreventive strategy in lung cancer clinics.  (+info)

*Adenosquamous carcinoma

... is a type of cancer that contains two types of cells: squamous cells (thin, flat cells that line ... Adenosquamous carcinoma entry in the public domain NCI Dictionary of Cancer Terms This article incorporates public domain ... Di Como, Joseph A. (October 2015). "Adenosquamous carcinoma of the colon and rectum: a population based clinical outcomes study ... Mahendraraj, Krishnara; Di Como, Joseph A. (October 2014). "Adenosquamous carcinoma of the pancreas: a population based ...

*Adenosquamous lung carcinoma

Squamous cell carcinoma Small cell carcinoma Adenocarcinoma Large cell carcinoma Adenosquamous carcinoma Sarcomatoid carcinoma ... Adenosquamous lung carcinoma (AdSqLC) is a biphasic malignant tumor arising from lung tissue that is composed of at least 10% ... In the 1960s, small cell lung carcinoma (SCLC) was recognized as a unique form of lung cancer, based both on its appearance ( ... Approximately 98% of lung cancers are carcinoma, which are tumors composed of cells with epithelial characteristics. LCLC's are ...

*Medroxyprogesterone acetate

... and risk of invasive adenocarcinomas and adenosquamous carcinomas of the uterine cervix. WHO Collaborative Study of Neoplasia ... Thomas DB, Ye Z, Ray RM (January 1995). "Cervical carcinoma in situ and use of depot-medroxyprogesterone acetate (DMPA). WHO ...

*Cancer of unknown primary origin

... or adenosquamous carcinomas.[medical citation needed] CUP is a term that refers to many different cancers. For that reason, ... A PET CT scan should be done for squamous cell carcinoma involving lymph nodes of the neck region. For other types of cancer of ... "Carcinoma of Unknown Primary Treatment-for health professionals". National Cancer Institute. December 30, 2014. Retrieved 6 ... Krishnatreya M, Sharma JD, Kataki AC, Kalita M (2014). "Survival in carcinoma of unknown primary to neck nodes treated with ...

*Lung cancer

... such as adenosquamous carcinoma. Rare subtypes include carcinoid tumors, bronchial gland carcinomas and sarcomatoid carcinomas ... Lung cancers are carcinomas-malignancies that arise from epithelial cells. Lung carcinomas are categorized by the size and ... The two main types are small-cell lung carcinoma (SCLC) and non-small-cell lung carcinoma (NSCLC). The most common symptoms are ... For therapeutic purposes, two broad classes are distinguished: non-small-cell lung carcinoma and small-cell lung carcinoma. The ...

*Giant-cell carcinoma of the lung

Small-cell carcinoma Squamous cell carcinoma Adenocarcinoma Large-cell carcinoma Adenosquamous carcinoma Sarcomatoid carcinoma ... Giant-cell carcinoma of the lung (GCCL) is a rare histological form of large-cell lung carcinoma, a subtype of undifferentiated ... Only small-cell carcinoma and large-cell carcinoma had shorter average survival.) Most GCCL have already grown and invaded ... including squamous cell carcinoma, and spindle cell carcinoma. The overall five-year survival rate in GCCL varies between ...

*Pancreatic cancer

Other exocrine cancers include adenosquamous carcinomas, signet ring cell carcinomas, hepatoid carcinomas, colloid carcinomas, ... undifferentiated carcinomas, and undifferentiated carcinomas with osteoclast-like giant cells. Solid pseudopapillary tumor is a ... The next most common type, acinar cell carcinoma of the pancreas, arises in the clusters of cells that produce these enzymes, ... Like the 'functioning' endocrine cancers described below, acinar cell carcinomas may cause over-production of certain molecules ...

*Colorectal cancer

"Colorectal carcinoma". Radiopaedia.org. Retrieved 13 September 2014. Di Como, Joseph A. (October 2015). "Adenosquamous ... adenosquamous and squamous cell carcinoma. Some subtypes have been found to be more aggressive. Cancers on the right side of ... Fungating carcinoma of the colon Micrographs (H&E stain) Cancer - Invasive adenocarcinoma (the most common type of colorectal ... Mitrovic, B.; Schaeffer, D. F.; Riddell, R. H.; Kirsch, R. (2012). "Tumor budding in colorectal carcinoma: Time to take notice ...

*Carcinoma

Adenosquamous carcinoma Refers to a mixed tumor containing both adenocarcinoma and squamous cell carcinoma, wherein each of ... In some types of carcinomas, Stage 0 carcinoma has been used to describe carcinoma in situ, and occult carcinomas detectable ... Some carcinomas are named for their or the putative cell of origin, (e.g.hepatocellular carcinoma, renal cell carcinoma). ... and sarcomatoid carcinoma (mixtures of spindle and giant cell carcinoma). Pleomorphic carcinoma contains spindle cell and/or ...

*List of MeSH codes (C04)

... carcinoma, adenosquamous MeSH C04.557.470.200.165 --- carcinoma, basal cell MeSH C04.557.470.200.165.150 --- basal cell nevus ... carcinoma, adenosquamous MeSH C04.557.435.290 --- carcinosarcoma MeSH C04.557.435.290.210 --- carcinoma 256, walker MeSH ... carcinoma, ehrlich tumor MeSH C04.557.470.200.220 --- carcinoma, giant cell MeSH C04.557.470.200.240 --- carcinoma in situ MeSH ... carcinoma, krebs 2 MeSH C04.557.470.200.260 --- carcinoma, large cell MeSH C04.557.470.200.280 --- carcinoma, lewis lung MeSH ...

*Cervical cancer

... adenosquamous carcinoma small cell carcinoma neuroendocrine tumour glassy cell carcinoma villoglandular adenocarcinoma ... Histologic subtypes of invasive cervical carcinoma include the following: Though squamous cell carcinoma is the cervical cancer ... Dürst M, Gissmann L, Ikenberg H, zur Hausen H (1983). "A papillomavirus DNA from a cervical carcinoma and its prevalence in ... Jones WB, Mercer GO, Lewis JL, Rubin SC, Hoskins WJ (1993). "Early invasive carcinoma of the cervix". Gynecol. Oncol. 51 (1): ...

*Sarcomatoid carcinoma of the lung

Squamous cell carcinoma Small cell carcinoma Adenocarcinoma Large cell carcinoma Adenosquamous carcinoma Sarcomatoid carcinoma ... pleomorphic carcinoma, (2) spindle cell carcinoma, (3) giant cell carcinoma, (4) carcinosarcoma, or (5) pulmonary blastoma. ... Carcinoid tumor Salivary gland-like carcinoma Sarcomatoid carcinomas are unique among lung carcinomas in that, although they ... Sarcomatoid carcinoma of the lung is a term that encompasses five distinct histological subtypes of lung cancer, including (1) ...

*Combined small-cell lung carcinoma

Squamous cell carcinoma Small cell carcinoma Adenocarcinoma Large cell carcinoma Adenosquamous carcinoma Sarcomatoid carcinoma ... Combined small cell lung carcinoma (or c-SCLC, and rarely rendered as "small-cell lung carcinoma") is a form of multiphasic ... and giant cell carcinoma. Giant cell carcinoma components are seen much more commonly in patients who have undergone radiation ... Nevertheless, small cell carcinomas (including the c-SCLC variant) still comprise 15-20% of all lung cancers, with c-SCLC ...

*Large-cell lung carcinoma with rhabdoid phenotype

... cell lung carcinoma Small cell lung carcinoma Adenocarcinoma of the lung Large cell lung carcinoma Adenosquamous carcinoma ... squamous cell carcinoma, combined large cell neuroencrine carcinoma, and mucinous bronchioloalveolar carcinoma and combined ... Similar to nearly all variants of lung carcinoma, large cell lung carcinoma with rhabdoid phenotype appears to be highly ... squamous cell carcinoma)., and that rhabdoid carcinomas often show similar features. Some evidence suggests that cells with the ...

*Salivary gland-like carcinoma of the lung

Squamous cell carcinoma Small cell carcinoma Adenocarcinoma Large cell carcinoma Adenosquamous carcinoma Sarcomatoid carcinoma ... adenoid cystic carcinoma of the lung, epithelial-myoepithelial carcinoma of the lung, and other (even more rare) variants. . ... Salivary gland-like carcinomas of the lung generally refers a class of rare cancers that arise from the uncontrolled cell ... Carcinoma is a term for malignant neoplasms derived from cells of epithelial lineage, and/or that exhibit cytological or tissue ...

*Epithelial-myoepithelial carcinoma of the lung

Squamous cell carcinoma Small cell carcinoma Adenocarcinoma Large cell carcinoma Adenosquamous carcinoma Sarcomatoid carcinoma ... In the lung, two salivary gland-like carcinomas, mucoepidermoid carcinoma and adenoid cystic carcinoma, while extremely ... Epithelial-myoepithelial carcinoma of the lung (EMECL) is a very rare histologic form of malignant epithelial neoplasm (" ... EMECL is staged in the same manner as other non-small cell lung carcinomas, based on the TNM (Tumor-Node-Metastasis) staging ...

*Adrenocortical carcinoma

Oncocytic adrenal cortical carcinoma Myxoid adrenal cortical carcinoma Carcinosarcoma Adenosquamous adrenocortical carcinoma ... Adrenocortical carcinoma is a rare tumor, with incidence of 1-2 per million population annually. Adrenocortical carcinoma has a ... Adrenocortical carcinoma (ACC, adrenal cortical carcinoma, adrenal cortical cancer, adrenal cortex cancer, etc.) is an ... Adrenocortical adenoma Renal cell carcinoma Adrenal medullary tumors Hepatocellular carcinoma The only curative treatment is ...

*International Classification of Diseases for Oncology

M8560/3 Adenosquamous carcinoma Mixed adenocarcinoma and squamous cell carcinoma Mixed adenocarcionma and epidermoid carcinoma ... NOS Reserve cell carcinoma Round cell carcinoma Small cell neuroendocrine carcinoma M8042/3 Oat cell carcinoma (C34._) M8043/3 ... Renal cell carcinoma, spindle cell M8319/3 collecting duct carcinoma (C64.9) Bellini duct carcinoma Renal carcinoma, collecting ... NOS Condylomatous carcinoma Verrucous squamous cell carcinoma Verrucous epidermoid carcinoma Warty carcinoma M8052/0 Squamous ...
From 1 July 1974 to 31 December 1982, 127 patients with primary carcinoma of the cervix were assessed to determine the prognosis of patients with adenosquamous cell carcinoma. Of all patients, 34 are dead of disease for an overall corrected survival rate of 73.2%. The survival of 20 patients with adenosquamous cell carcinoma is 20%. Seventy-five percent of the adenosquamous cell patients had stage IB lesions. When patients with adenosquamous cell carcinoma were compared with patients with squamous cell carcinoma or adenocarcinoma, there was a statistically significant decrease in survival. Patients with adenosquamous cell carcinoma were relatively young with a mean age of 41.1 years. A normal appearing cervix was noted in 30% of all patients with adenosquamous cell carcinoma. The majority of adenosquamous cell patients (87.5%) dead from cancer had distant metastases. This report emphasizes that, independent of stage, adenosquamous cell cervical carcinoma is an extremely aggressive neoplasm and ...
The aim of the present study was to examine the epidemiology, natural history, treatment and long-term survival of patients with adenosquamous cell carcinoma of the prostate. The Surveillance, Epidemiology, and End Results (SEER) Program database was used ...
Human Cervix Adenosquamous Cell Carcinoma, Grade 2, Stage II, Female, Age 40 Tumor/normal adjacent tissue lysate set, 100 �g each, $270. 1.800.475.1955
PubMed Central Canada (PMC Canada) provides free access to a stable and permanent online digital archive of full-text, peer-reviewed health and life sciences research publications. It builds on PubMed Central (PMC), the U.S. National Institutes of Health (NIH) free digital archive of biomedical and life sciences journal literature and is a member of the broader PMC International (PMCI) network of e-repositories.
Helpful, trusted answers from doctors: Dr. Holzman on adenosquamous carcinoma lung: There could be genetic component to a squamous cell cancer, although the exact implications on treatment arent known. Obviously if there is a strong family history of cancers, or if it strikes someone who is young and/or a non smoker/drinker i would suspect a strong genetic contribution. Without more details, it is hard to say with any certainty.
Grant] United States / NCI NIH HHS / CA / CA 12213; United States / NCI NIH HHS / CA / CA 12644; United States / NCI NIH HHS / CA / CA 13612; United States / NCI NIH HHS / CA / CA 22433; United States / NCI NIH HHS / CA / CA 32102; United States / NCI NIH HHS / CA / CA 35090; United States / NCI NIH HHS / CA / CA 35178; United States / NCI NIH HHS / CA / CA 35192; United States / NCI NIH HHS / CA / CA 35262; United States / NCI NIH HHS / CA / CA 35431; United States / NCI NIH HHS / CA / CA 38926; United States / NCI NIH HHS / CA / CA 42777; United States / NCI NIH HHS / CA / CA 45450; United States / NCI NIH HHS / CA / CA 45461; United States / NCI NIH HHS / CA / CA 46136; United States / NCI NIH HHS / CA / CA 46441; United States / NCI NIH HHS / CA / CA 52654; United States / NCI NIH HHS / CA / CA 58861; United States / NCI NIH HHS / CA / CA 76132; United States / NCI NIH HHS / CA / CA ...
PubMed comprises more than 30 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
PubMed comprises more than 30 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
Low-Grade Adenosquamous Carcinoma of the Breast Developing Around a Localization Wire Fragment. Handa, Priyanka; Khader, Samer N.; Buchbinder, Shalom S.; Guelfguat, Mark // Laboratory Medicine;Summer2015, Vol. 46 Issue 3, p241 We present the case of a 67-year-old white woman with a history of benign biopsy results in the previous 10 years before she developed low-grade adenosquamous carcinoma around a residual localization wire fragment. A possible theory of carcinogenesis may be related to reparative epithelium in a... ...
This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must be interpreted in the context of a patients clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician ...
Im over here from gyn boards but wanted to throw my two cents in on the adeno subject. HPV can cause cancer in the cells of squamous or the glandular adenocarcinoma. I have adenosquamous carcinoma of the cervix, a rare form of cervical cancer but none the less, hpv associated cervical cancer. Most anal cancers are also hpv related. The probable reason for the more drastic surgical approach is because theadenocarcinomas tend to behave more aggressively than the squamous, and are more resistant to chemo and radiation. They require a more aggressive treatment plan to eliminate and control. I had a radical hysterectomy, chemo, chemo/rads and more chemo and still had a recurrence in the lung two months after completing treatment. I was originally staged at 2a. Had more surgery and chemo and am now NED. I would support the surgery to remove the cancer. We are strong and we adapt. I am 34 with three kids under the age of10 and will do whatever I have to to stick around for them. Good luck to you and ...
One of two basic types of lung cancer. Non-small cell tumors grow slowly but are less likely to respond to chemotherapy. There are different subtypes of non-small cell lung cancer: adenocarcioma, squamous cell carcinoma, adenosquamous carcinoma, larger cell carcinoma, and undifferentiated carcinoma.
Anaplastic lymphoma kinase (ALK) is positive in 2-5% of patients with non-small cell lung cancer (NSCLC). At least 28 different EML4-ALK variants have been identified in NSCLC, but clinical significance of each variant is unknown. Patients with ALK-positive disease tend to be younger, never-light smokers, presenting with adenocarcinoma, adenosquamous carcinoma, and rarely squamous cell carcinoma (SCC). Pleural and pericardial effusion and brain metastases are more common among patients with ALK-positive tumours.. ALK testing should be carried out simultaneously with EGFR at diagnosis of advanced NSCLC. ALK mutation testing is recommended in all patients with advanced NSCLC of a non-squamous subtype regardless of smoking history. Testing is not recommended in patients with an unequivocal diagnosis of SCC, except in never/former light smokers. This E-Learning module elaborates clinical characteristics in patients with ALK-positive NSCLC and provides evidence from clinical studies with ALK ...
Activation of ras oncogenes is commonly found in human neoplasms. We have investigated 280 human lung cancer specimens for ras activation, including 38 that have not been reported previously, using an oligonucleotide detection assay. From a total of 141 adenocarcinoma samples from smokers, 41 tested positive for a point mutation in codon 12 of K-ras (30%), while three tumors had another type of ras activation. Only two of 40 cases from nonsmokers had a K-ras mutation (5%), suggesting that K-ras mutations may be directly caused by exposure to carcinogens in tobacco smoke. The majority of the point mutations in adenocarcinomas were guanine to thymine transversions in codon 12 of the K-ras oncogene. Occasional point mutations in ras oncogenes were detected in adenosquamous carcinomas (one of five cases) and large cell carcinoma (one of 24 cases), but no ras activations were found in small cell carcinomas (six cases), squamous carcinomas (48 cases), carcinoid carcinomas (15 cases), or thymoma (one ...
Papillomas or warts are easily recognized skin or mucous membrane tumors. They are common in wild species and are particularly well known in deer (Cosgrove and Fay 1981; Sundberg and Nielson 1981). Most of these tumors are caused by papillomaviruses (PVs). Tumors can become quite large and numerous and persist for prolonged periods, but they usually regress, providing the individual with long-term immunity to future infections. Occasionally, the tumors will progress to squamous cell carcinoma, adenosquamous carcinoma, or sebaceous carcinoma that will eventually kill the host if not treated. Specific mucosotropic PV types and those infecting immunodeficient individuals are prone to induce malignancies. Virtually all mammalian species are hosts for one of more PV. This chapter provides an overview of PV infections in mammals ...
真木 健裕 , 原 敬志 , 平野 聡 , 田中 栄一 , 斉藤 克憲 , 竹内 幹也 , 七戸 俊明 , 佐藤 幸作 , 三品 壽雄 , 近藤 哲 日本消化器外科学会雑誌 40(11), 1811-1815, 2007-11-01 CiNii PDF - オープンアクセス 医中誌Web 参考文献19件 被引用文献2件 ...
Papillary squamous cell carcinoma (PSCC) of the uterine cervix is difficult to diagnose due to its rarity and limited data regarding its clinical behavior. We attempted to assess the degree of stromal invasion using magnetic resonance imaging (MRI) and evaluate possible treatments for this lesion in view of its clinical behavior. We analyzed 28 cases of PSCC diagnosed on the colposcopic selective biopsies. We studied the rate of accuracy of diagnoses of the colposcopic selective biopsies compared with the final diagnoses, and compared the rate of stromal invasion between the MRI and pathological findings while focusing on surgical methods and the clinical prognosis. Of the 28 patients, only 12 exhibited true PSCC. The other 16 patients were ultimately diagnosed with SCC or adenosquamous carcinoma based on the finding of the surgical specimens and exhibited relatively poor prognoses. Among the 12 true PSCC cases, the rate of diagnostic accuracy of stromal invasion (with or without) was only 58% (7/12) on
Five hundred and sixty-five cases of large bowel cancer were analysed. There were 8 (1.4%) appendiceal tumours, 296 (52.4%) colonic cancers, 236 (41.8%) rectal cancers, 6 (1.1%) anal cancers and 19 (3.4%) multiple primary cancers of the large bowel. Non-mucinous adenocarcinoma was by far the commonest histological type of large bowel cancer (74.7%). This was followed by mucinous carcinoma (20.7%). Other histological types were relatively uncommon. They included carcinoid tumours (1.8%), signet-ring cell carcinoma (1.5%), squamous cell carcinoma (0.7%), undifferentiated carcinoma (0.4%) and adenosquamous carcinoma (0.2%). The proportion of mucinous carcinoma was greater among the Indians and Malays than among the Chinese. There was a positive correlation between the grade and extent of spread of the tumour. The right colon had greater proportion of poorly differentiated adenocarcinomas than the left colon; this tendency was more evident in females. Mucinous carcinoma tended to occur more ...
Cervical cancer occurs primarily in 2 varieties: squamous cell carcinoma (about 80% of cases) and adenocarcinoma (about 15%). Adenosquamous carcinoma makes up most of the remaining cases, and this type may have a poorer outcome. A rare cause of death when screening programs exist, cervical cancer accounts for about 1% of all cancer deaths in developed countries. Cervical cancer is age related; incidence is extremely low in women under 20, and peaks at 16.5/100,000/year in women aged 45 to 49.1. Symptoms are absent in many cases, but abnormal vaginal discharge or bleeding often occurs. Advanced disease may also cause pain in the low back and pelvis with radiation into the posterior legs, as well as bowel or urinary symptoms such as passage of blood and a sensation of pressure. ...
As the most common and most important cancer of the pancreas, with rapid mortality and now also as the third leading cause of cancer-related deaths in the United States, pancreatic ductal adenocarcinoma (PDAC) has become synonymous with "pancreas cancer". PDAC is also the prototype of the "pancreatobiliary-type" adenocarcinomas, along the biliary tract, ampullary and gallbladder cancers with the similar morphology and behavior. Recent molecular profiling studies have identified distinct subsets of PDAC, potentially with different behaviors and targetability. Moreover, while PDAC is by far the most common cancer of the pancreas, there are various other types that occur in this organ and are erroneously classified together with PDAC. Many of these have different molecular and biologic characteristics that warrant their management separately although they are also technically "pancreatic cancers". While some are closely related to PDAC and have as aggressive behavior (such as adenosquamous ...
This is a phase 2 study. Patients with advanced or metastatic histologically documented squamous cell carcinoma, adenocarcinoma, or adenosquamous cancers originating in the cervix, vagina, or vulva will be eligible. Measurable disease by either clinical exam or radiography is also required. Patients receiving cisplatin-based chemoradiation as definitive treatment for local disease will be eligible. Patients must have no more than one prior platinum-based chemotherapy regimen in the metastatic setting. Patients presenting with distant metastatic disease (beyond the pelvis) will be eligible, as long as they are not eligible for a higher priority study ...
There were no significant differences in the clinicopathological characteristics of the patients. Mean age was 45 years (range 24 - 70). In both groups the histologies were squamous cell carcinoma (70%), adenocarcinoma (20%), and adenosquamous (10%). Stage distribution according to the FIGO was as follows: IB2, 22.5%; IIA, 10%; IIB, 67.5%, in both groups. Overall, 100% of patients completed external beam, and surgery or intracavitary brachyterapy. The majority of patients received the planned six courses of weekly cisplatin. At median follow-up (28 months; range 2-58 months), overall survival is 78% and 75% (p , 0.05) for the surgical and brachytherapy groups of patients. ...
Clinicopathological evidence has accumulated that colorectal adenocarcinoma with minimal or no glandular differentiation constitutes two entities with different prognosis. In a series of 20 predominantly nonglandular, poorly differentiated adenocarcinomas, histological features, DNA content, p53 protein expression, Ki-ras mutation, and microsatellite instability were analyzed and correlated to the biology of the tumors. In addition, the presence of Epstein-Barr virus (EBV) transcripts was tested by RNA in situ hybridization and EBV DNA was demonstrated by nested polymerase chain reaction. Histologically, 13 tumors showed small uniform cells and 7 tumors showed large pleomorphic cells. Tumors with uniform cells exhibited more commonly an expansive growth pattern (69.2% versus 0%; P | 0.025) and a dense peritumor lymphoid infiltrate (84.6% versus 14.3%; P | 0.01) resembling their gastric counterpart, solid or medullary carcinoma. These tumors showed less frequent lymph node as well as hematogeneous
Pill with imprint CG GOG is Gray / Pink, Capsule-shape and has been identified as Diovan 160 mg. It is supplied by Novartis Pharmaceuticals.
FINAL DIAGNOSIS:. HIGH-GRADE UROTHELIAL CARCINOMA WITH PLASMACYTOID, MICROPAPILLARY AND GLANDULAR DIFFERENTIATION.. DISCUSSION:. This tumor is a poorly differentiated invasive carcinoma, which shows glandular and divergent patterns of differentiation. There is no discrete papillary urothelial carcinoma component or urothelial carcinoma in situ. The tumor shows undifferentiated plasmacytoid histology, glandular differentiation and solid sheet-like architecture (similar to high-grade urothelial carcinoma). Because of the divergent differentiations, the possibility of a metastasis from a primary (like breast or stomach) was considered but was clinically unlikely (with negative mammography and endoscopy). The immunohistochemical profile with the positivity of CK7 and CK20 supports the urothelial origin of this tumor.. A micropapillary variant of transitional cell carcinoma (TCC) was first described in 1994 by Amin et al (1). Four morphological features were described as being distinct to this ...
Recently, in a retrospective analysis, Kang et al. (27) showed that the use of CT-based 3D BT resulted in a significant decrease of severe late rectal bleeding and in an improvement of LC for patients with tumor size >4 cm. In a retrospective series including 84 patients with primary locally. advanced cervical carcinoma, Haie-Meder et al. (28) http://www.selleckchem.com/products/i-bet-762.html suggest that applying individual treatment planning with 3D MRI-guided LDR BT is feasible and efficient in routine clinical practice and should become the standard modality of gynecologic BT. In 2006, A French prospective multicentric study STIC PDR (Programme de Soutien aux Techniques Innovantes Coûteuses Pulsed Dose Rate) was initiated for patients treated for. cervix carcinoma comparing a PDR BT method based on orthogonal x-rays (two-dimensional group) or based on 3D imaging (3D group). Their results in the 3D arm at 2 years (LC, locoregional control [LRC], and DFS) are relatively similar to ours at 5 ...
Expression of ANLN (ANILLIN, scra, Scraps) in spleen tissue. Antibody staining with HPA005680, HPA050556, CAB033902, CAB062547 and CAB068175 in immunohistochemistry.
Expression of ANLN (ANILLIN, scra, Scraps) in oral mucosa tissue. Antibody staining with HPA005680, HPA050556, CAB033902 and CAB062547 in immunohistochemistry.
BACKGROUND: Definitive chemoradiotherapy is a curative treatment option for oesophageal carcinoma, especially in patients unsuitable for surgery. The PRODIGE5/ACCORD17 trial aimed to assess the efficacy and safety of the FOLFOX treatment regimen (fluorouracil plus leucovorin and oxaliplatin) versus fluorouracil and cisplatin as part of chemoradiotherapy in patients with localised oesophageal cancer. METHODS: We did a multicentre, randomised, open-label, parallel-group, phase 2/3 trial of patients aged 18 years or older enrolled from 24 centres in France between Oct 15, 2004, and Aug 25, 2011. Eligible participants had confirmed stage I-IVA oesophageal carcinoma (adenocarcinoma, squamous-cell, or adenosquamous), Eastern Cooperative Oncology Group (ECOG) status 0-2, sufficient caloric intake, adequate haematological, renal, and hepatic function, and had been selected to receive definitive chemoradiotherapy. Patients were randomly assigned (1:1) to receive either six cycles (three concomitant to ...
Background: Versican, an extracellular matrix proteoglycan, has been noted to be expressed in several malignant tumours and has been suggested to play an important role in cancer development and tumour growth.. Aims: To investigate whether the versican expression level in the peritumoural stromal tissue of primary oral squamous cell carcinoma (OSCC) predicts relapse-free or disease-specific survival. Also, to study the associations between versican expression and several other clinicopathological variables, as well as tumour cell proliferation.. Methods: Immunohistochemistry was used to study the expression of versican and tumour cell proliferative activity in 139 OSCCs. All pertinent clinical data were collected retrospectively from the hospital records.. Results: In this cohort, versican expression did not correlate with the clinicopathological factors or tumour cell proliferation. In univariate analyses, higher risk for disease recurrence was associated with higher stromal versican expression ...
Vajtai, I; Varga, Z; Aguzzi, A (1997). Pleomorphic xanthoastrocytoma with gangliogliomatous component. Pathology, Research and Practice, 193(9):617-621.. Vajtai, I; Varga, Z; Aguzzi, A (1996). MIB-1 immunoreactivity reveals different labelling in low-grade and in malignant epithelial neoplasms of the choroid plexus. Histopathology, 29(2):147-151.. Varga, Z; Vajtai, I; Aguzzi, A (1996). The standard isoform of CD44 is preferentially expressed in atypical papillomas and carcinomas of the choroid plexus. Pathology, Research and Practice, 192(12):1225-1231.. Varga, Z; Vajtai, I; Marino, S; Schäuble, B; Yonekawa, Y; Aguzzi, A (1996). Tubular adenoma of the choroid plexus: evidence for glandular differentiation of the neuroepithelium. Pathology, Research and Practice, 192(8):840-844.. ...
Microscopic description: Urothelial carcinoma may show features of low grade or high grade carcinoma (1). This particular FNA from an axillary lymph node shows a monomorphic population of relatively bland appearing epithelioid cells. If not for the scattered mitotic figures and location, it may be difficult at first glance to recognize this specimen as a malignant process. Urothelial carcinomas may appear cohesive, as in this example, or loose to discohesive. High grade urothelial carcinomas are usually more pleomorphic and discohesive. Cercariform cells and eosinophilic bodies (Melamed-Wolinska bodies) may be seen (2). Necrosis is a common occurrence in high grade lesions. Further complicating diagnosis is the occasional presence of squamous differentiation, glandular differentiation, or spindle cells usually seen in high grade lesions. Differential Diagnosis: Clinical history is important to keeping urothelial carcinoma in your differential, particularly in low grade appearing lesions. ...
GOG.com is a digital distribution platform - an online store with a curated selection of games, an optional gaming client giving you freedom of choice, and a vivid community of gamers. All of this born from a deeply rooted love for games, utmost care about customers, and a belief that you should own the things you buy. What is GOG.com about? ...
Background: Radical hysterectomy with pelvic lymphadenectomy is one of the FIGO (International Federation of Gynecology and Obstetrics) recommended treatments for early cervical cancer. The objective of this study was to compare radical hysterectomy by laparoscopic approach and open radical hysterectomy in a single center randomized clinical trial. Nevertheless, there are no finished randomized controlled trials comparing laparoscopic radical hysterectomy and abdominal radical hysterectomy although there is an ongoing trial.. Methods: Were enrolled 30 IA2 with lymph vascular space invasion and IB cervical cancer patients. Postoperative pain intensity was defined as primary endpoint and pain intensity was measured by a 10-point numeric rating scale. Secondary outcomes were: intraoperative and other postoperative outcomes, histopathological outcomes and 5-year follow-up. Data analysis is being done at this moment ...
The International Federation of Film Archives (FIAF) brings together institutions dedicated to rescuing of films both as art and as historical documents
The International Federation of Film Archives (FIAF) brings together institutions dedicated to rescuing of films both as art and as historical documents

Adenosquamous carcinoma lung - What Does the Doctor Say?Adenosquamous carcinoma lung - What Does the Doctor Say?

Holzman on adenosquamous carcinoma lung: There could be genetic component to a squamous cell cancer, although the exact ... Are carcinoid tumors carcinoma? Is malignant metastatic stomach carcinoma thats hereditary a carcinoid cancer? carcinoid ... small cell carcinoma and large cell carcinoma. In squamous cell cancer, the tumor cells resemble skin cells. This type of tumor ... Basal cell carcinoma rarely travels to other parts of the body, but will recur locally if not treated appropriately. Squamous ...
more infohttps://www.healthtap.com/topics/adenosquamous-carcinoma-lung

Poor prognosis in patients with adenosquamous cell carcinoma of the cervixPoor prognosis in patients with adenosquamous cell carcinoma of the cervix

When patients with adenosquamous cell carcinoma were compared with patients with squamous cell carcinoma or adenocarcinoma, ... A normal appearing cervix was noted in 30% of all patients with adenosquamous cell carcinoma. The majority of adenosquamous ... Poor prognosis in patients with adenosquamous cell carcinoma of the cervix. Gallup DG, Harper RH, Stock RJ. Abstract:. From 1 ... The survival of 20 patients with adenosquamous cell carcinoma is 20%. Seventy-five percent of the adenosquamous cell patients ...
more infohttp://imsdd.meb.uni-bonn.de/cgi-bin/mycite?ExtRef=MEDL/85138937/PMID/3974967

Clinical features and outcomes of 25 patients with primary adenosquamous cell carcinoma of the prostateClinical features and outcomes of 25 patients with primary adenosquamous cell carcinoma of the prostate

Adenosquamous carcinoma of the prostate with elevated serum parathyroid hormonerelated protein and squamous cell carcinoma ... mixed types of carcinoma of the prostate are rare.1,2 Adenosquamous cell carcinoma (ASCC) is defined by the presence of both ... 8. Devaney DM, Dorman A, Leader M. Adenosquamous carcinoma of the prostate: a case report. Hum Pathol. 1991;22:1046-50. [PubMed ... Adenosquamous cell carcinoma is a rare aggressive subtype of prostate cancer with a poor outcome. Further study to understand ...
more infohttp://pubmedcentralcanada.ca/pmcc/articles/PMC2994527/

Clinical features and outcomes of 25 patients with primary adenosquamous cell carcinoma of the prostate - Open Access LibraryClinical features and outcomes of 25 patients with primary adenosquamous cell carcinoma of the prostate - Open Access Library

... treatment and long-term survival of patients with adenosquamous cell carcinoma of the prostate. The Surveillance, Epidemiology ... Primary renal adenosquamous carcinoma. Outcomes and Prognostic Factors for Adenocarcinoma/Adenosquamous Carcinomas Treated with ... Branchiogenic Basaloid Squamous Cell Carcinoma with Adenosquamous Features. Branchiogenic Carcinoma in the Setting of Another ... Keywords: Surveillance , Epidemiology , and End Results (SEER) , Adenosquamous cell carcinoma (ASCC) of the prostate , Cancer ...
more infohttp://www.oalib.com/paper/2502781

Cervix (Human) Tissue Lysate � Adenosquamous Cell Carcinoma � T4-014Cervix (Human) Tissue Lysate � Adenosquamous Cell Carcinoma � T4-014

Human Cervix Adenosquamous Cell Carcinoma, Grade 2, Stage II, Female, Age 40 Tumor/normal adjacent tissue lysate set, 100 �g ...
more infohttp://www.proteinbiotechnologies.com/products/cervix/t4_014_human_cervix_tissue_lysate.html

adenosquamous cell carcinoma of cervix uteri 2005:2010[pubdate] *count=100 - BioMedLib™ search engineadenosquamous cell carcinoma of cervix uteri 2005:2010[pubdate] *count=100 - BioMedLib™ search engine

Carcinoma, Adenosquamous / drug therapy. Carcinoma, Adenosquamous / pathology. Carcinoma, Adenosquamous / surgery. Carcinoma, ... Carcinoma, Adenosquamous / pathology. Carcinoma, Adenosquamous / radiotherapy. Carcinoma, Adenosquamous / surgery. Carcinoma, ... Carcinoma, Adenosquamous / genetics. Carcinoma, Adenosquamous / pathology. Carcinoma, Adenosquamous / virology. Carcinoma, ... Carcinoma, Adenosquamous / metabolism. Carcinoma, Adenosquamous / pathology. Carcinoma, Squamous Cell / metabolism. Carcinoma, ...
more infohttp://www.bmlsearch.com/?kwr=adenosquamous+cell+carcinoma+of+cervix+uteri+2005:2010%5Bpubdate%5D&cxts=100&stmp=b0

Primary Gallbladder Cancer Discovered Postoperatively after Elective and Emergency Cholecystectomy | proLékaře.czPrimary Gallbladder Cancer Discovered Postoperatively after Elective and Emergency Cholecystectomy | proLékaře.cz

The precursor lesions of invasive gallbladder carcinoma. Hyperplasia, atypical hyperplasia and carcinoma in situ. Cancer 1980; ... Less common types include papillary, muqinous, squamous and adenosquamous [16]. Malignancy is usually diagnosed on pathological ... The median survival for incidental carcinomas is 26.5 months and for suspected carcinomas is 9.2 months [2,7,26]. Important for ... Carcinoma of the gallbladder. Lancet Oncol 2003; 4(3): 167- 176. 43. Zhu AX, Hong TS, Hezel AF et al. Current management of ...
more infohttps://www.prolekare.cz/en/journals/clinical-oncology/2013-1-4/primary-gallbladder-cancer-discovered-postoperatively-after-elective-and-emergency-cholecystectomy-40015

Endometrial Adenosquamous Carcinoma - DrugBankEndometrial Adenosquamous Carcinoma - DrugBank

This project is supported by the Canadian Institutes of Health Research (award #111062), Alberta Innovates - Health Solutions, and by The Metabolomics Innovation Centre (TMIC), a nationally-funded research and core facility that supports a wide range of cutting-edge metabolomic studies. TMIC is funded by Genome Alberta, Genome British Columbia, and Genome Canada, a not-for-profit organization that is leading Canadas national genomics strategy with funding from the federal government. Maintenance, support, and commercial licensing is provided by OMx Personal Health Analytics, Inc. Designed by Educe Design & Innovation Inc. ...
more infohttps://www.drugbank.ca/indications/DBCOND0029160

Adenosquamous carcinoma - definition of adenosquamous carcinoma by The Free DictionaryAdenosquamous carcinoma - definition of adenosquamous carcinoma by The Free Dictionary

adenosquamous carcinoma synonyms, adenosquamous carcinoma pronunciation, adenosquamous carcinoma translation, English ... dictionary definition of adenosquamous carcinoma. n. pl. car·ci·no·mas or car·ci·no·ma·ta An invasive malignant tumor derived ... carcinoma. n carcinoma m; basal cell - carcinoma basocelular; bronchogenic - carcinoma broncogénico; ductal - in situ carcinoma ... Acantholytic squamous cell carcinoma, Spindle cell carcinoma and Adenosquamous carcinoma.. ORAL SQUAMOUS CELL CARCINOMA: A ...
more infohttp://www.thefreedictionary.com/adenosquamous+carcinoma

Salivary glands - Adenosquamous carcinomaSalivary glands - Adenosquamous carcinoma

Adenosquamous carcinoma. Reviewer: Adriana Handra-Luca, M.D. (see Reviewers page) Revised: 24 January 2013, last major update ... Adenosquamous carcinoma (figure A) and other tumors with basal cell features. Positive stains. ... End of Salivary glands > Epithelial / myoepithelial tumors > Adenosquamous carcinoma. This information is intended for ... squamous cell carcinoma and mixtures resembling mucoepidermoid carcinoma. ● Adjacent tumors may cause multifocal carcinoma in ...
more infohttp://www.pathologyoutlines.com/topic/salivaryglandsadenosquamous.html

Adenosquamous carcinoma - WikipediaAdenosquamous carcinoma - Wikipedia

Adenosquamous carcinoma is a type of cancer that contains two types of cells: squamous cells (thin, flat cells that line ... Adenosquamous carcinoma entry in the public domain NCI Dictionary of Cancer Terms This article incorporates public domain ... Di Como, Joseph A. (October 2015). "Adenosquamous carcinoma of the colon and rectum: a population based clinical outcomes study ... Mahendraraj, Krishnara; Di Como, Joseph A. (October 2014). "Adenosquamous carcinoma of the pancreas: a population based ...
more infohttps://en.wikipedia.org/wiki/Adenosquamous_carcinoma

Adenosquamous Carcinoma Arising in Choledochal CystAdenosquamous Carcinoma Arising in Choledochal Cyst

Adenosquamous carcinma MeSH Terms expand_less. expand_more. Abdominal Pain Adult Biliary Tract Carcinoma, Adenosquamous ... Adenosquamous Carcinoma Arising in Choledochal Cyst.. Hyun JH , Lee HS , Lee SW , Song CW , Ryu HS , Kang DH , Kim CD , Kim JW ... Pathologic studies disclosed an adenosquamous carcinoma. Author Keywords expand_less. expand_more. Choledochal cyst ... Recently we experienced a case of carcinoma arising in a choledochal cyst in 27-year-old male complaining jaundice and fever. ...
more infohttps://koreamed.org/article/0027KJGE/1994.14.2.196

Cutaneous adenosquamous carcinoma: a rare neoplasm with biphasic differentiation.Cutaneous adenosquamous carcinoma: a rare neoplasm with biphasic differentiation.

Cutaneous adenosquamous carcinoma (cASC) is an extremely rare malignant neoplasm. Due to its disputed pathophysiology, ... Cutaneous adenosquamous carcinoma (cASC) is an extremely rare malignant neoplasm. Due to its disputed pathophysiology, ...
more infohttp://www.biomedsearch.com/nih/Cutaneous-adenosquamous-carcinoma-rare-neoplasm/25474451.html

Diagnostic histological features of metastatic lymph nodes in adenosquamous carcinoma.Diagnostic histological features of metastatic lymph nodes in adenosquamous carcinoma.

Laryngeal adenosquamous carcinoma (ASC) is a rare malignancy, and the problems in true diagnosis of this entity are well known ... Adenosquamous carcinoma is a distinct entity and must be distinguished from the common SCC of larynx. As a result, when a ... Laryngeal adenosquamous carcinoma (ASC) is a rare malignancy, and the problems in true diagnosis of this entity are well known ... Based on incisional biopsy, diagnosis of squamous cell carcinoma (SCC) was made and total laryngectomy with bilateral radical ...
more infohttp://www.biomedsearch.com/nih/Diagnostic-histological-features-metastatic-lymph/22572038.html

EGFR and KRAS mutations in Chinese patients with adenosquamous carcinoma of the lung.  - PubMed - NCBIEGFR and KRAS mutations in Chinese patients with adenosquamous carcinoma of the lung. - PubMed - NCBI

Adenosquamous carcinoma (ADSQ) is uncommon in non-small cell lung cancer (NSCLC). The frequency rate of ADSQ was 9.7% of 6990 ... EGFR and KRAS mutations in Chinese patients with adenosquamous carcinoma of the lung.. Jia XL1, Chen G. ... Many researches have analyzed genetic and molecular alterations in adenocarcinoma (AD) and squamous cell carcinoma (SQ), but ... Carcinoma, Adenosquamous/epidemiology. *Carcinoma, Adenosquamous/genetics*. *Carcinoma, Adenosquamous/pathology. *Carcinoma, ...
more infohttps://www.ncbi.nlm.nih.gov/pubmed/21592614?dopt=Abstract

A Rare Case of Penile Metastases as a Harbinger of Primary Pulmonary Adenosquamous CarcinomaA Rare Case of Penile Metastases as a Harbinger of Primary Pulmonary Adenosquamous Carcinoma

... Partha Hota,1 Tejas N. Patel,2 ... "A Rare Case of Penile Metastases as a Harbinger of Primary Pulmonary Adenosquamous Carcinoma," Case Reports in Radiology, vol. ...
more infohttps://www.hindawi.com/journals/crira/2018/8361368/cta/

CiNii 論文 - 
 		
 		
 			
 		 	
 		 		
 		 			Adenosquamous carcinoma of the gall-bladder with gastric foveolar-type epithelium
...CiNii 論文 - Adenosquamous carcinoma of the gall-bladder with gastric foveolar-type epithelium ...

Adenosquamous carcinoma of the gall-bladder with gastric foveolar-type epithelium * * NISHIHARA Kazuyoshi ... Adenosquamous carcinoma of the gallbladder with spindle cell features. A light microscopic and immunohistochemical study of a ... Adenosquamous carcinoma of the gallbladder : a clinicopathological, immunohistochemical and flow-cytometric study of twenty ... Stromal osteoclast-like giant cells in an adenosquamous carcinoma of the gallbladder GROSSO LE ...
more infohttp://ci.nii.ac.jp/naid/10008329490

Mutations of epidermal growth factor receptor and K-ras genes in adenosquamous carcinoma of the lung.  - PubMed - NCBIMutations of epidermal growth factor receptor and K-ras genes in adenosquamous carcinoma of the lung. - PubMed - NCBI

Mutations of epidermal growth factor receptor and K-ras genes in adenosquamous carcinoma of the lung.. Toyooka S, Yatabe Y, ...
more infohttps://www.ncbi.nlm.nih.gov/pubmed/16187277?dopt=Abstract

Adenosquamous lung carcinoma - WikipediaAdenosquamous lung carcinoma - Wikipedia

Squamous cell carcinoma Small cell carcinoma Adenocarcinoma Large cell carcinoma Adenosquamous carcinoma Sarcomatoid carcinoma ... Adenosquamous lung carcinoma (AdSqLC) is a biphasic malignant tumor arising from lung tissue that is composed of at least 10% ... In the 1960s, small cell lung carcinoma (SCLC) was recognized as a unique form of lung cancer, based both on its appearance ( ... Approximately 98% of lung cancers are carcinoma, which are tumors composed of cells with epithelial characteristics. LCLCs are ...
more infohttps://en.wikipedia.org/wiki/Adenosquamous_lung_carcinoma

Adenosquamous carcinoma of the esophagus: A literature review : Journal of Translational Internal MedicineAdenosquamous carcinoma of the esophagus: A literature review : Journal of Translational Internal Medicine

... "adenosquamous carcinoma" and MECE was classified to the subclass type of "adenosquamous carcinoma". Finally, in the 9th GCPSCE ... Keywords: adenosquamous carcinoma; esophageal cancer; esophageal carcinoma; esophageal tumor; esophageal malignancy. ... In conclusion, adenosquamous carcinoma is a rare type of esophageal tumor that is challenging to diagnose prior to surgery. ... Adenosquamous carcinoma (ASC) of the esophagus is an uncommon type of esophageal cancer that contains both adenocarcinoma and ...
more infohttps://content.sciendo.com/abstract/journals/jtim/6/2/article-p70.xml

Cervical adenosquamous carcinomaCervical adenosquamous carcinoma

Build: Sat Nov 17 23:53:08 EST 2018 (commit: a759bb7). National Center for Advancing Translational Sciences (NCATS), 6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-435-0888. ...
more infohttps://pharos.nih.gov/idg/diseases/DOID:5636

Imaging Diagnosis: Computed Tomographic Findings In A Case Of Adenosquamous Carcinoma Of The Head And Neck In A Cat | Advanced...Imaging Diagnosis: Computed Tomographic Findings In A Case Of Adenosquamous Carcinoma Of The Head And Neck In A Cat | Advanced...

Imaging Diagnosis: Computed Tomographic Findings In A Case Of Adenosquamous Carcinoma Of The Head And Neck In A Cat. by Heather ... Postmortem biopsy samples acquired from the calvarium yielded a histologic diagnosis of sinonasal adenosquamous carcinoma, a ...
more infohttps://avmi.net/information/ct-concepts/imaging-diagnosis-computed-tomographic-findings-in-a-case-of-adenosquamous-carcinoma-of-the-head-and-neck-in-a-cat/

Patient with De Novo Adenosquamous Carcinoma of the Prostate - BJUIPatient with De Novo Adenosquamous Carcinoma of the Prostate - BJUI

Adenosquamous carcinoma of the prostate. Int J Urol, 2005; 12(3): 319-21.. 8. Parwani AV, Kronz JD, Genega EM, et al. Prostate ... Primary adenosquamous cell carcinoma of the prostate (ASC) is an exceedingly rare and aggressive form of prostate cancer. Since ... Primary adenosquamous cell carcinoma of the prostate (ASC) is an exceedingly rare and aggressive form of prostate cancer, ... Prostatic Adenosquamous Carcinoma Metastasizing to Testis. The Scientific World Journal, 2006; 6: 2491-2494.. 7. Egilmez T, Bal ...
more infohttp://www.bjuinternational.com/case-studies/patient-de-novo-adenosquamous-carcinoma-prostate/

Adenosquamous carcinoma of the pancreas associated with humoral hypercalcemia of malignancy (HHM) - GeoScience.netAdenosquamous carcinoma of the pancreas associated with humoral hypercalcemia of malignancy (HHM) - GeoScience.net

Adenosquamous carcinoma of the pancreas associated with humoral hypercalcemia of malignancy (HHM) ... This is a very rare report of adenosquamous cell carcinoma of the pancreas associated with HHM. US$19.90 ... Adenosquamous carcinoma of the pancreas associated with humoral hypercalcemia of malignancy (HHM). ... We report a rare case of adenosquamous carcinoma of the pancreas associated with humoral hypercalcemia of malignancy (HHM) in ...
more infohttps://geoscience.net/research/051/377/051377070.php
more